Kamada Ltd
- Last sale
- Oct 12, 2026 · -2.85%
- Market cap
- $452.84M
- 57.69M shares
- Filings
- 539
FY 2025+12.1% FY25 yoy
FY 2025+39.7% FY25 yoy
FY 2025+30.8% FY25 yoy
—
—
—FY 2025+40.0% FY25 yoy
FY 2025−3.8% FY25 yoy
- $452.84M
- 22.4×
- 2.5×
- 1.7×
- —
- 2.55%
Twelve months to Dec 31, 2025 · derived
Price
Oct 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $180,460,000 | reported | |
| FY 2024 | 2024-12-31 | $160,953,000 | reported | |
| FY 2023 | 2023-12-31 | $142,519,000 | reported | |
| FY 2022 | 2022-12-31 | $129,339,000 | reported | |
| FY 2021 | 2021-12-31 | $103,642,000 | reported | |
| FY 2020 | 2020-12-31 | $133,246,000 | reported | |
| FY 2019 | 2019-12-31 | $127,187,000 | reported | |
| FY 2018 | 2018-12-31 | $114,469,000 | reported | |
| FY 2017 | 2017-12-31 | $102,825,000 | reported | |
| FY 2016 | 2016-12-31 | $77,494,000 | reported | |
| FY 2015 | 2015-12-31 | $69,906,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $11.53M | — | $11.53M | — | 57.69M sh | +0.3% | — |
Segments
LineFY2022ShareChange
Reportable Segments$102.60M79%+35.9%
All Other Segments$26.74M21%−4.9%
Total$129.34M
Pharmaceutical preparations
Kamada Ltd is the 89th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
RYTMRhythm Pharmaceuticals, Inc.$189.8M45.8%103.6%$7.6BMRVIMaravai Lifesciences Holdings, Inc.$185.7M28.3%70.4%$2.0BSTOKStoke Therapeutics, Inc.$184.4M404.5%3.7%$1.7BLFVNLifevantage Corp$182.6M20.1%2.8%$64.0M
KMDAKamada Ltd (this company)$180.5M12.1%11.2%$452.8M
CYRXCryoport, Inc.$176.2M12.4%44.4%$968.4MPHATPhathom Pharmaceuticals, Inc.$175.1M216.9%126.3%$506.9MSNDXSyndax Pharmaceuticals Inc$172.4M627.8%165.6%$1.3BLQDALiquidia Corp$158.3M1,031.2%43.5%$5.2BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Kamada Ltd · CIK 1567529 · Engraved from SEC EDGAR